Dr. Alfred Hansel
Dr. Alfred Hansel, together with Dr. Martina Schmitz, has been leading oncgnostics GmbH since its foundation in February 2012. As CEO, he is responsible for the business development of oncgnostics GmbH. After his PhD in molecular microbiology (University of Freiburg i. Br.), he gained many years of experience in project management by working at domestic and foreign university institutions, as well as operational experience in industry in the business areas of product development, sales and marketing. The spin-off of oncgnostics GmbH is based on his scientific work in the functional area "Gynecological Molecular Biology", as well as a project group, which he led.